2025 英卡思巴黎国际年会
大会日程

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Co-founder

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: approved
和审阅情况: 2005

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: INMODE

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: ACTIVE
和审阅情况: QUANTUM PATENT

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Inmode

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： Inmode

Objectives: 1. Appropriate case selection for the Quantum 10 in the face
2. When to use Quantum 10 and when to use Facetite
3. Results from a 3-year experience of the author in this technology

Introduction: The introduction of Quantum10RF technology marks a groundbreaking advancement in the field of aesthetic medicine. This innovative device operates using a bipolar radiofrequency (RF) mechanism that delivers ultra-short pulse RF energy beneath the skin or deeper into the fat layer. This approach facilitates the dual benefit of fat coagulation and skin tightening, achieving superior outcomes in rejuvenating the neck and lower third of the face. Quantum10RF represents a paradigm shift in minimally invasive aesthetics, offering unparalleled efficiency, precision, and safety.

Materials / method: This presentation draws from the senior author’s extensive clinical experience, encompassing over 35 cases treated with Quantum10RF over the past two years. These cases will be analyzed to highlight clinical efficiency, procedural approaches, and key insights into optimizing patient outcomes.

Results: Key findings include the development of a practical algorithm for determining when to utilize Quantum10RF versus FaceTite, ensuring tailored treatment for each patient. The presentation will emphasize the safety

Conclusion: Quantum10RF represents a transformative advancement in neck and lower third facial rejuvenation, combining unparalleled safety, efficiency, and precision. Its innovative bipolar RF mechanism, delivering ultra-short pulse energy beneath the skin and into the fat, allows for simultaneous fat coagulation and skin tightening, producing remarkable aesthetic outcomes. The integration of techniques such as the Bilayer Sculpting Technique ensures comprehensive, tailored treatments that enhance both contour and skin quality. With a proven safety profile and versatility, Quantum10RF is a game-changer.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: INMODE

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: INMODE

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: INMODE

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： INMODE

Objectives: Bipolar radiofrequency (RF) technology has undergone significant advancements, introducing groundbreaking upgrades that revolutionize its applications in the aesthetic and medical fields. The latest developments enable a single probe, the bipolar RF 10-piece, to be used effectively for both fat coagulation and skin tightening, as well as for achieving superior results in fat reduction and treatment of various pathologies. In addition to these advancements, enhanced safety features and performance optimizations have been integrated into the technology, offering users improved precision.

Introduction: The field of bipolar RF technology has seen remarkable progress, driven by the integration of new technologies and insights. These advancements have enabled the creation of a versatile single-probe bipolar RF 10-piece system that excels in both fat coagulation and skin tightening. This upgraded device now offers clinicians and practitioners enhanced capabilities in addressing a range of aesthetic and therapeutic concerns with improved safety and efficiency. Among these innovations, the latest updates to the Morpheus system stand out, offering optimized results in RF-based fractional treatment.

Materials / method: The session is a live 20-minute panel discussion featuring some of the world’s foremost authorities on bipolar RF technology. These experts will share their clinical experiences, focusing on the practical application of the updated technology and the benefits it offers. Audience interaction is encouraged through the use of a QR code, allowing attendees to submit questions in real-time and engage directly with the panel.

Results: Panelists will discuss their experiences with the upgraded bipolar RF technology, emphasizing its versatile application in both fat coagulation and skin tightening, along with its enhanced safety features and optimized performance. Real-world outcomes, challenges, and practical tips will be shared to guide practitioners in achieving optimal results.

Conclusion: This session promises to be an invaluable platform for specialists and users of bipolar RF technology. It provides an opportunity for attendees to gain insights from leading experts, address pressing questions, and enhance their understanding of how to optimize outcomes with the latest advancements in bipolar RF fractional and internal treatments. The event underscores the potential of these upgrades to redefine the standards of care and innovation in the field.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: INMODE

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: INMODE

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： INMODE

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: Co-founder

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: approved
和审阅情况: 2005

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
是
请注明名称（个人，公司，学会等等）: INMODE

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
是
请注明日期: ACTIVE
和审阅情况: QUANTUM RF PATENT

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。